New injection aims to stop dangerous blood sugar crashes after gastric bypass
Disease control
Ongoing
This study is testing if a daily injection called avexitide can safely reduce episodes of dangerously low blood sugar in people who have had gastric bypass surgery. About 75 participants will receive either the real injection or a placebo (dummy shot) for 16 weeks, followed by a …
Phase: PHASE3 • Sponsor: Amylyx Pharmaceuticals Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC